Trilegal Strengthens Life Sciences And Healthcare Practice With Ashwin Sapra As Equity Partner
Trilegal Strengthens Life Sciences and Healthcare Practice with Ashwin Sapra as Equity Partner
The leading one of India’s law firms, Trilegal, has strengthened its life sciences and healthcare capabilities with the addition of seasoned lawyer Ashwin Sapra as an equity partner in the corporate practice. Ashwin brings over 25 years of domestic and international experience advising clients across the healthcare, pharmaceutical, medical device, diagnostics, and life sciences sectors.
With his joining, Trilegal’s partnership strength will increase to 151, reflecting the firm’s continued focus on building sector-specialised expertise. As private capital, digital health initiatives, and regulatory reforms reshape India’s healthcare and life sciences sector, Trilegal’s strengthened leadership enhances its capabilities to advise industry participants and investors in navigating this evolving environment.
Commenting on the Appointment
Commenting on the appointment, Nishant Parikh and Sridhar Gorthi, Partners and Members of the Management Committee at Trilegal, said,
“Ashwin is a highly seasoned practitioner whose experience aligns well with the firm’s integrated, cross-practice model. He will play a key role in the firm’s rapidly growing healthcare, pharmaceutical, medical device, and life sciences capabilities, adding depth and expertise to our client advisory competencies across transactional, disputes, regulatory, and intellectual property matters.”
On his joining, Ashwin Sapra said,
“The healthcare sector in India is at an important stage of growth, with increased investment activity and regulatory engagement. Trilegal’s integrated platform, sector focus, and global standing provide an opportunity to work closely with clients on their most critical legal and business issues. I look forward to working with the team to support healthcare and life sciences clients across mandates.”
About Ashwin Sapra
Ashwin Sapra brings over 25 years of domestic and international experience across pharmaceutical, medical devices, life sciences, and healthcare transactions, disputes, advisory, intellectual property, and policy matters. He has successfully leveraged this expertise in a collaborative, cross-functional manner, offering strategic and commercially viable solutions aligned with global and domestic best practices, experience-based foresight, and client expectations.
His deep subject-matter knowledge, industry insight, and strong professional relationships provide a competitive edge for organisations actively involved in advisory in this sector. Ashwin is widely recognised for his proficiency in regulatory compliance, disputes, medical device laws, clinical trial regulations, and IP strategy. He has extensive experience advising clients on complex issues related to drug approvals, drugs and medical device product liability, marketing practices/anti-kickback laws, and IP portfolio management.
Education and Background
- LL.M. in Intellectual Property, Duke University
- LL.B., Symbiosis Law College
- B.Sc. in Zoology, Delhi University
Ashwin combines international exposure with a nuanced understanding of global and domestic regulatory frameworks and business practices. Frequently ranked by leading legal directories, he is a sought-after speaker and thought leader on healthcare policy, innovation, and emerging trends in life sciences and medical technology.
Click to know more about Trilegal
If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.
